This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1016/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q43707069
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel 2012年學術文章 articol științific scientific article vetenskaplig artikel article científic tieteellinen artikkeli 2012年の論文 2012年學術文章 artículo científico publicado en 2012 ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2012年学术文章 tudományos cikk naučni članak article scientific سائنسی مضمون artikulong pang-agham vitenskapelig artikkel мақолаи илмӣ 2012年學術文章 videnskabelig artikel (udgivet 2012) мақолаи илмӣ artigo científico (publicado na 2012) 2012年學術文章 επιστημονικό άρθρο 2012年学术文章 научна статия scienca artikolo مقالة علمية บทความทางวิทยาศาสตร์ מאמר מדעי 2012年学术文章 articolo scientifico wissenschaftlicher Artikel научни чланак teaduslik artikkel vedecký článok 2012년 논문 artículu científicu espublizáu en 2012 2012年學術文章 bilimsel makale bài báo khoa học article scientifique (publié 2012) 2012 nî lūn-bûn مقالهٔ علمی наукова стаття, опублікована в листопаді 2012 2012年學術文章 artigo científico գիտական հոդված 2012年学术文章 wetenschappelijk artikel научная статья artykuł naukowy artikull shkencor научни чланак 2012年学术文章 mokslinis straipsnis artigo científico (publicado na 2012) vědecký článek სამეცნიერო სტატია
p:P577
wds:Q43707069-4661A5F6-3D4B-45E9-BC4B-6EA0C61D9F91
wdt:P577
2012-11-08T00:00:00Z
p:P2860
wds:Q43707069-083AA622-5690-4C31-BB6E-AC1916097F0F
wdt:P2860
wd:Q34079116
p:P2093
wds:Q43707069-62393390-88B0-4632-8C34-7F97C6B1EAD5 wds:Q43707069-686732C3-ECAE-4A12-8AF1-EB2BF6F11C45 wds:Q43707069-516B2FBA-775C-4199-896B-FBF4C63C1ABC wds:Q43707069-F2D4C438-A54E-4E6B-A92D-89C71850CB34 wds:Q43707069-971FF2D7-94A6-44AE-9741-0C6F13F9AA31 wds:Q43707069-7DCE6A00-73DF-4FA2-9AFF-36713121F5CB wds:Q43707069-B13FD342-05FC-4830-A0DE-4678702125E5
wdt:P2093
Benedetto Bruno Francesca Patriarca Alessandra Sperotto Ilaria Scortechini Renato Fanin Pinuccia Valagussa Mauro Montanari
rdfs:label
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation
skos:prefLabel
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation
schema:name
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation
p:P50
wds:Q43707069-85DBA6C0-E0A8-4CD0-81E3-62AC8FD76FC2 wds:Q43707069-D368C255-CC92-404F-AD06-2D93B2294570 wds:Q43707069-E8BA9D42-DD39-48BD-8D76-A6B57CFD57F2 wds:Q43707069-330E007F-4153-4E3A-ADE5-627AE3BD935F wds:Q43707069-5816979D-7519-4BE7-97D4-BD92A0443A55 wds:Q43707069-70F49FB8-FCA3-4588-98F8-03FF2FF4B911
wdt:P50
wd:Q42234542 wd:Q42234553 wd:Q37838318 wd:Q57061792 wd:Q54772696 wd:Q42234531
p:P1476
wds:Q43707069-0A93EAF9-9ABA-478E-930A-90068CEE2586
wdt:P1476
Bortezomib plus dexamethasone followed by escalating donor lymphocyte infusions for patients with multiple myeloma relapsing or progressing after allogeneic stem cell transplantation
p:P304
wds:Q43707069-1E2F5906-284B-478F-97A4-AEB4677E3654
wdt:P304
424-428
p:P31
wds:Q43707069-FB3540F9-D617-439F-8B00-99301AD18BA3
wdt:P31
wd:Q13442814
p:P921
wds:Q43707069-2B7DFE37-FC8F-41C9-B513-C849A32327E8 wds:Q43707069-69BA8C92-5E73-453B-BF65-DADEF1199374
wdt:P921
wd:Q422252 wd:Q715347
p:P698
wds:Q43707069-6B49F51E-680A-4F7A-863D-83A9DF46B693
wdtn:P698
n12:23142330
wdt:P698
23142330
p:P1433
wds:Q43707069-12B8EEA9-A56A-4FC1-9818-ED8A2667C08F
wdt:P1433
wd:Q15754328
p:P433
wds:Q43707069-00029C21-34C4-441A-BA35-95BB8CC0A1DD
p:P478
wds:Q43707069-DDDF92E1-98D5-492E-A069-DFB122DEE877
wdt:P433
3
wdt:P478
19
p:P356
wds:Q43707069-9AB21616-2F7D-4E71-BEDF-347F0B8C5A73
wdtn:P356
n11:J.BBMT.2012.10.032
wdt:P356
10.1016/J.BBMT.2012.10.032
p:P5875
wds:Q43707069-75B0573D-87AD-4C9C-B5CF-5151F297968F
wdt:P5875
233394538